Early Weight Gain Predicting Later Weight Gain Among Depot Medroxyprogesterone Acetate Users
نویسندگان
چکیده
منابع مشابه
Infant weight gain and later blood pressure.
To the Editor: Recently, Law et al1 reported that increased weight gain during early childhood (1 to 5 years) but not during infancy (birth to 1 year) is associated with later systolic blood pressure. From the latter, they concluded that “. . . none of the evidence so far indicates that promotion of infant growth increases cardiovascular risk.”1 In our opinion, this conclusion is not only incor...
متن کاملWeight gain and incident obesity among male snus users
BACKGROUND Snus is a moist smokeless tobacco product which has recently reached beyond its original market of Scandinavia. Snus is now being increasingly used in both the United States and South Africa. The effect of snus use on weight is unknown. This study has therefore investigated the relationship between the use of snus, weight gain (≥5%) and the incidence of obesity (body mass index ≥30 k...
متن کاملPatterns of Maternal Weight Gain During Pregnancy and Birth Weight
Anthropometric parameters are an important indicator of health and nutritional status comprising the whole span of mans life. However, they are not of the same degree of simplicity and sensitivity in assessing the public health status. During recent decades many studies have attempted to examine the relationships of these measurements in order to present simple alternatives for similar purposes...
متن کاملPatterns of Weight Gain and Birth Weight Amongst Indian Women
Background: The timing of maternal weight change in pregnancy may be an important determinant of birth weight. The objective of this study was to measure weight gain patterns from early pregnancy until delivery, and to examine the relationship between prenatal weight gain and low birth weight. Methods: A total of 500 pregnant women within 15-20 days of conception, with confirmed pregnancies and...
متن کاملMedroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial☆☆☆
OBJECTIVE To describe medroxyprogesterone acetate (MPA) levels among Kenyan depot medroxyprogesterone acetate (DMPA) users in the FEM-PrEP HIV prevention trial, and to compare MPA levels between ARV for HIV prevention (treatment) and placebo groups. STUDY DESIGN We measured MPA in previously collected plasma samples from 63 Kenyan trial participants who used DMPA for one or two complete inter...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Obstetrics & Gynecology
سال: 2009
ISSN: 0029-7844
DOI: 10.1097/aog.0b013e3181af68b2